Oura Partners with Eli Lilly to Track GLP-1 Drug Users' Health — Smart Rings Enter the Pharma Ecosystem

Oura has partnered with Eli Lilly's LillyDirect platform to provide GLP-1 weight-loss drug users with continuous health monitoring through the Oura Ring. The deal marks one of the first major partnerships between a consumer smart ring company and a pharmaceutical giant, positioning the Oura Ring as a clinical companion device.

How the Partnership Works

• Data integration: Oura Ring health metrics — sleep, heart rate, HRV, body temperature, activity — feed directly into LillyDirect's patient dashboard
• GLP-1 context: Patients on medications like Mounjaro and Zepbound can track how their body responds to treatment through continuous biometric monitoring
• Medicare tie-in: Coincides with the federal Medicare GLP-1 Bridge Program (July 2026 – December 2027), expanding access to these drugs
• Physician access: Oura also partnered with Counsel Health to let users share ring data directly with healthcare providers

Why This Matters for the Smart Ring Market

This is a pivotal moment for smart rings. Moving from consumer wellness to pharmaceutical integration validates the accuracy and usefulness of smart ring health data at a clinical level. Oura already leads the market with 76.4% share, and pharma partnerships create a moat that competitors like Samsung, RingConn, and Ultrahuman will struggle to match. Smart ring shipments are projected to jump 49% year-over-year, and partnerships like this accelerate mainstream adoption.

Oura's Growing Health Ecosystem

The Eli Lilly deal is just one piece of Oura's expanding health platform. Recent partnerships include Mira for hormone tracking, Dexcom for continuous glucose monitoring via the Stelo sensor, and ResMed for sleep apnea detection. The Oura Ring 5 launched in May with blood pressure trend monitoring and nighttime breathing analysis, further strengthening the clinical case.

What This Means for Buyers

If you're on a GLP-1 medication or considering one, the Oura Ring 4 at $349 or Oura Ring 5 at $399 just became more useful — your ring data can now feed into your care plan. For general health tracking without a subscription, the Samsung Galaxy Ring at $399 remains a strong alternative, though it lacks Oura's pharma partnerships. Compare all options in our smart ring guide.